Comparison of the effect of rupivacaine 0.2 and bupivacaine 0.2 in the transversus abdominis plane block (TAP) under ultrasound guidance in management of acute pain after open appendectomy

Comparative study of the effect of rupivacaine 0.2 and bupivacaine 0.2 in the transversus abdominis plane block (TAP) under ultrasound guidance in management of acute pain after open appendectomy ( Clinical Trial )

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211112053042N1

Enrollment

Registered

2021-11-23

Start date

2021-12-05

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain after open appendectomy. Other acute postprocedural pain

Interventions

Intervention 1: Intervention group: These patients will receive 20 ml of rupivacaine 0.2% and develop TAP block under ultrasound guide. Intervention 2: Control group: These patients will receive 20 ml

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 18 to 60 years Patients with consent to participate in the project

Exclusion criteria

Exclusion criteria: Coagulation disorders Chronic abdominal pain Substance and alcohol abuse Dissatisfaction with participating in the project

Design outcomes

Primary

Measure	Time frame
Intensity of pain. Timepoint: 2, 4, 6, 8, 12, 24 and 48 hours after transverse abdominal muscle block. Method of measurement: Ask the patient based on the visual analog scale (0= No pain, 1-3=Mild, 4-7= Moderate, 8-10=Severe).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hossein Delshad MD.

Karaj University of Medical Sciences

m.delshad@abzums.ac.ir+98 26 3350 2347

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026